Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 1997

View Archived Issues

Vitamin E for maternal diabetes-associated malformations in offspring

In vitro profile of new quinolone: HSR-903

Second-generation NNRTI under development by Hoechst/Bayer

Abbott describes SAR leading to prokinetic motilides

SKB describes development of 5-HT4 antagonists for IBS

New antiarthritic agent from Czech research institute characterized

Gene Logic and P&G alliance for heart failure drug discovery

Pharmacokinetics of DW-116, ciprofloxacin and rufloxacin compared in animals

Roche seeks FDA approval for humanized antibody

Valaciclovir has comparable efficacy and safety to aciclovir in recurrent genital herpes

BMS-180048 vs. placebo for acute treatment of migraine

Vertex and Lilly join forces in hepatitis C drug development

Boston Life Sciences receives notice of patent allowance for CNS growth factor

Friedreich's ataxia: possible cause and potential treatments

Amersham and P&U form new company

ID Vaccine and the University of British Columbia collaborate on bacterial vaccines

Cellegy discovers compounds that modulate topical inflammatory and allergic responses

Natural remedy for the common cold evaluated in controlled clinical trial

AEterna's IND for Neoretna approved in Canada

NYU grants Medco option to license adenosine A2 agonists

Botulinum toxin type A evaluated in cerebral palsy

Gensia Sicor's GenESA System assigned new indication

Positive results reported for clot imaging agent MH-1

Glaxo Wellcome acquires Spectra Biomedical

U.S. notice of patent allowance for troponin I

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...